MedTrace Logo

A Study of Huperzine A Injection in Reducing Postoperative Delirium in Elderly Patients Undergoing Non-cardiac Surgery

NCT05242419 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-04-02

No results posted yet for this study

Summary

To observe and study the clinical effect of Huperzine A Injection on reducing postoperative delirium in elderly patients undergoing non-cardiac surgery

Conditions

  • Injection
  • Non-cardiac Surgery
  • Delirium in Old Age
  • Post Operative Delirium

Interventions

DRUG

Sodium Chloride Injection

0.9% Sodium Chloride Injection

DRUG

Huperzine A Injection

Huperzine A Injection

Sponsors & Collaborators

  • Affiliated Wenling Hospital of Wenzhou Medical University

    collaborator OTHER

  • Second Affiliated Hospital of Wenzhou Medical University

    lead OTHER

Principal Investigators

  • Ting Li, MD. PhD · Second Affiliated Hospital of Wenzhou Medical University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-10
Primary Completion
2025-11-30
Completion
2025-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05242419 on ClinicalTrials.gov